These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36878409)

  • 1. Effect of antimicrobial consumption on Escherichia coli resistance: assessment and forecasting using Dynamic Regression models in a French university hospital (2014-2019).
    Laffont-Lozes P; Salipante F; Leguelinel-Blache G; Dunyach-Remy C; Lavigne JP; Sotto A; Larcher R
    Int J Antimicrob Agents; 2023 May; 61(5):106768. PubMed ID: 36878409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of dynamic regression time series models for studying the relationship between antimicrobial consumption and bacterial antimicrobial resistance in hospitals: a systematic review.
    Laffont-Lozes P; Larcher R; Salipante F; Leguelinel-Blache G; Dunyach-Remy C; Lavigne JP; Sotto A; Loubet P
    Antimicrob Resist Infect Control; 2023 Sep; 12(1):100. PubMed ID: 37697357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between antimicrobial consumption and resistance rate of Escherichia coli in hospital settings.
    Abdullah S; Rahman SU; Muhammad F; Mohsin M
    J Appl Microbiol; 2023 Jan; 134(1):. PubMed ID: 36626753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global antimicrobial resistance and use surveillance system (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries.
    Ajulo S; Awosile B
    PLoS One; 2024; 19(2):e0297921. PubMed ID: 38315668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
    Hsueh PR; Chen WH; Luh KT
    Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in South Korean antimicrobial use and association with changes in Escherichia coli resistance rates: 12-year ecological study using a nationwide surveillance and antimicrobial prescription database.
    Kim YA; Park YS; Youk T; Lee H; Lee K
    PLoS One; 2018; 13(12):e0209580. PubMed ID: 30596704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced rates of antimicrobial resistance in Staphylococcus intermedius group and Escherichia coli isolated from diseased companion animals in an animal hospital after restriction of antimicrobial use.
    Kurita G; Tsuyuki Y; Murata Y; Takahashi T;
    J Infect Chemother; 2019 Jul; 25(7):531-536. PubMed ID: 30905629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between antimicrobial consumption and resistance in Escherichia coli.
    Bergman M; Nyberg ST; Huovinen P; Paakkari P; Hakanen AJ;
    Antimicrob Agents Chemother; 2009 Mar; 53(3):912-7. PubMed ID: 19104012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolone-Resistant and Extended-Spectrum β-Lactamase-Producing Escherichia coli Infections in Patients with Pyelonephritis, United States(1).
    Talan DA; Takhar SS; Krishnadasan A; Abrahamian FM; Mower WR; Moran GJ;
    Emerg Infect Dis; 2016 Sep; 22(9):1594-603. PubMed ID: 27532362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management.
    Kaye KS; Gupta V; Mulgirigama A; Joshi AV; Scangarella-Oman NE; Yu K; Ye G; Mitrani-Gold FS
    Clin Infect Dis; 2021 Dec; 73(11):1992-1999. PubMed ID: 34143881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stepwise Expansion of Antimicrobial Stewardship Programs and Its Impact on Antibiotic Use and Resistance Rates at a Tertiary Care Hospital in Korea.
    Shin DH; Kim HS; Heo E; Shin MJ; Kim NH; Lee H; Park JS; Park KU; Jung J; Song KH; Kang M; Jung J; Kim ES; Kim HB
    Microbiol Spectr; 2022 Jun; 10(3):e0033522. PubMed ID: 35467411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and characteristics of fecal antimicrobial-resistant Escherichia coli in a cohort of Japanese men undergoing prostate biopsy.
    Kamei J; Yagihara Y; Kume H; Horiuchi T; Sato T; Nakagawa T; Fujimura T; Fukuhara H; Moriya K; Homma Y
    Int J Urol; 2017 Apr; 24(4):295-300. PubMed ID: 28222483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Determinants of Resistance to Extended-Spectrum Cephalosporin and Fluoroquinolone in Escherichia coli Isolated from Diseased Pigs in the United States.
    Hayer SS; Lim S; Hong S; Elnekave E; Johnson T; Rovira A; Vannucci F; Clayton JB; Perez A; Alvarez J
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33115839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends and relationship between antimicrobial resistance and antibiotic use in Xinjiang Uyghur Autonomous Region, China: Based on a 3 year surveillance data, 2014-2016.
    Wushouer H; Zhang ZX; Wang JH; Ji P; Zhu QF; Aishan R; Shi LW
    J Infect Public Health; 2018; 11(3):339-346. PubMed ID: 29017750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial-resistant invasive Escherichia coli, Spain.
    Oteo J; Lázaro E; de Abajo FJ; Baquero F; Campos J;
    Emerg Infect Dis; 2005 Apr; 11(4):546-53. PubMed ID: 15829192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ECDC/EFSA/EMA second joint report on the integrated analysis of the consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals: Joint Interagency Antimicrobial Consumption and Resistance Analysis (JIACRA) Report.
    ; ;
    EFSA J; 2017 Jul; 15(7):e04872. PubMed ID: 32625542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals.
    MacDougall C; Powell JP; Johnson CK; Edmond MB; Polk RE
    Clin Infect Dis; 2005 Aug; 41(4):435-40. PubMed ID: 16028149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of fluoroquinolone resistance in Escherichia coli isolates at the department of clinical hematology.
    Zemkova M; Kotlarova J; Merka V; Cermak P; Vlcek J; Jebavy L
    New Microbiol; 2007 Oct; 30(4):423-30. PubMed ID: 18080678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone consumption and Escherichia coli resistance in Japan: an ecological study.
    Terahara F; Nishiura H
    BMC Public Health; 2019 Apr; 19(1):426. PubMed ID: 31014305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment.
    Pitout JD
    Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1165-76. PubMed ID: 23199402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.